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Abstract
Aims/Hypothesis: Reduced skeletal muscle insulin sensitivity is a feature associated with sustained exposure to excess
saturated fatty acids (SFA), whereas mono and polyunsaturated fatty acids (MUFA and PUFA) not only improve insulin
sensitivity but blunt SFA-induced insulin resistance. The mechanisms by which MUFAs and PUFAs institute these favourable
changes remain unclear, but may involve stimulating insulin signalling by counter-modulation/repression of protein
phosphatase 2A (PP2A). This study investigated the effects of oleic acid (OA; a MUFA), linoleic acid (LOA; a PUFA) and
palmitate (PA; a SFA) in cultured myotubes and determined whether changes in insulin signalling can be attributed to PP2A
regulation.
Principal Findings: We treated cultured skeletal myotubes with unsaturated and saturated fatty acids and evaluated insulin
signalling, phosphorylation and methylation status of the catalytic subunit of PP2A. Unlike PA, sustained incubation of rat or
human myotubes with OA or LOA significantly enhanced Akt- and ERK1/2-directed insulin signalling. This was not due to
heightened upstream IRS1 or PI3K signalling nor to changes in expression of proteins involved in proximal insulin signalling,
but was associated with reduced dephosphorylation/inactivation of Akt and ERK1/2. Consistent with this, PA reduced PP2Ac
demethylation and tyrosine307phosphorylation - events associated with PP2A activation. In contrast, OA and LOA strongly
opposed these PA-induced changes in PP2Ac thus exerting a repressive effect on PP2A.
Conclusions/Interpretation: Beneficial gains in insulin sensitivity and the ability of unsaturated fatty acids to oppose
palmitate-induced insulin resistance in muscle cells may partly be accounted for by counter-modulation of PP2A.
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Introduction
Sustained elevation in circulating non-esterified free fatty acids
(NEFA) as seen during obesity and Type 2 diabetes is associated
with impaired insulin signalling in tissues such as skeletal muscle
thus potentially contributing to disturbances in whole body glucose
metabolism in obese or diabetic individuals [1–3]. In particular,
over-provision of saturated fatty acids (SFA, e.g. palmitate) result
in tissue accumulation of lipotoxic fatty acid derivatives such as
diacylglycerol (DAG) and ceramide that promote activation of (i)
DAG-sensitive PKCs, (ii) atypical PKCs and (iii) PP2A that, in
turn, impair IRS- and Akt-directed insulin signalling by mecha-
nisms involving IRS serine phosphorylation or repression of Akt
activation/phosphorylation [4–9]. Strikingly, dietary substitution
of SFAs or co-supplementation with unsaturated fatty acids
antagonise the insulin desensitising effects of SFAs, enhance
energy expenditure and improve muscle lipid composition and
serum acylcarnitine profiles in humans [10–14]. Such observations
are in line with cell-based studies demonstrating that monounsat-
urated fatty acids (MUFAs), such as palmitoleate and oleate, not
only attenuate the SFA-induced loss in mitochondrial integrity and
function but also repress their proinflammatory and ER stress-
inducing potential [15–18]. Moreover, the observation that
increases in serum palmitoleate induce a strong insulin potenti-
ating effect in mouse liver and skeletal muscle implies that this
MUFA possesses unique metabolic attributes not held by its
saturated counter-part, palmitate [19]. However, despite the
observed gain in insulin sensitivity brought about by palmitoleate
in these peripheral tissues, our understanding of the underlying
mechanism remains poor [19].
In this study we have investigated the effects of oleic acid (OA; a
cis-C18:1, n-9 MUFA), and linoleic acid (LOA; a cis-C18:2, n-6
PUFA) upon insulin signalling events in cultured rat and human
skeletal myotubes. Our work reveals that both oleic acid and
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linoleic acid induce an increase in insulin sensitivity based on
enhanced Akt- and Erk-directed insulin signalling. These effects
cannot be attributed to an elevation in upstream IRS/PI3K
signalling but were associated with increased tyrosine phosphor-
ylation (Tyr307) and demethylation of the PP2A catalytic subunit
(PP2Ac) – covalent changes that help retain the phosphatase in a
repressed state [20,21]. In contrast, palmitate (PA) attenuated
tyrosine phosphorylation and demethylation of PP2Ac by insulin
in line with the known stimulatory effect that this SFA has upon
PP2A [22]. These PA-induced changes in PP2A were antagonised
by both OA and LOA. Our data indicate that increases in insulin
sensitivity brought about by exposure of muscle cells to OA and
LOA may, in part, be brought about by covalent modification and
cellular repression of PP2A.
Materials and Methods
Materials
a-minimal essential medium, fetal bovine serum and antibiotic/
antimycotic solution were from Life Technologies. All other
reagent-grade chemicals, including BSA and fatty acids, were
obtained from Sigma–Aldrich unless otherwise stated. Wortman-
nin and okadaic acid were from Calbiochem-Merck. Fraction V
fatty acid-free BSA was from Roche. Insulin was from R&D
systems. Complete protein phosphatase inhibitor tablets were
purchased from Roche Diagnostics. Phospho-AktThr308, phospho-
AktSer473, phospho-ERK1/2Thr202/Tyr204, phospho-GSK3Ser21/9,
phospho-CREBSer133, phospho-SrcTyr416, anti-Akt and anti-
ERK1/2 antibodies were from Cell Signaling Technology. Anti-
GSK3 and anti-PTEN antibodies were from Santa Cruz
Biotechnology. Anti-IR (insulin receptor), anti-p85, anti-IRS1
and anti-PP2A subunit C, demethylated were from Millipore.
Anti-b actin and anti-GAPDH were from Sigma. Phospho-
PP2AY307 was from Abcam.
Cell culture, fatty acid treatment and cell lysis
Human skeletal muscle cells derived from biopsies (quadriceps
muscle) from healthy adult lean volunteers obtained in the context
of approved preclinical and clinical trials [23], and via the Tissue
Bank for Research (Myobank) of the French Association against
Myopathies (AFM), in agreement with the French bioethical law
on informed consent. Rat L6 muscle cells were originally sourced
from Dr Amira Klip (Hospital For Sick Children, Toronto) [24].
Rat L6 and human skeletal myotubes were cultured as
described previously [25,26]. Myotubes were exposed to serum
free media containing 2% (w/v) fatty acid-free BSA alone (control
vehicle) or fatty acids that had been preconjugated to BSA (2% w/
v) at concentrations and for the times indicated in figure legends.
In some experiments myotubes were incubated with insulin (10
min) at concentrations indicated in figure legends. At the end of
appropriate experimental treatments cells were washed using cold
phosphate-buffered saline and lysed using lysis buffer [50 mM
Tris/HCl, pH 7.4, 0.27 M sucrose, 1 mM sodium orthovanadate,
1 mM EDTA, 1 mM EGTA, 10 mM sodium 2-glycerophosphate,
50 mM sodium fluoride, 5 mM sodium pyrophosphate, 1% (w/v)
Triton X-100, 0.1% (v/v) 2-mercaptoethanol and protease
inhibitor (one tablet/50 ml)]. Whole-cell lysates were centrifuged
for 10 min at 6000 rpm, 4uC and supernatant frozen in liquid
nitrogen prior to storage at -20uC. Protein concentration was
measured using the Bradford assay [27].
Immunoblotting, IRS-1 immunoprecipitation and analysis
of cellular PIP3
Proteins from cell lysates (30 mg) were separated by SDS-PAGE
and the abundance/activation status of specific proteins assessed
by immunoblotting [25] using primary antibodies to proteins of
interest followed by exposure to an appropriate peroxidase-
conjugated IgG for 1h at room temperature. Immunoreactive
bands were detected by enhanced chemiluminescence on Kodak
X-OMAT film and quantified using Image J software (http://
rsbweb.nih.gov/ij/). Analysis of p85-PI3K association with IRS1
and cellular PIP3 content were respectively assessed by coimmu-
noprecipitation with IRS1 and use of a sensitive time-resolved
fluorescence resonance energy transfer (FRET)-based assay as
described previously [28,29].
Statistical analyses
One-way ANOVA or a Student’s t test as appropriate was
performed using GraphPad Prism software with differences
considered statistically significant at P,0.05.
Results
Effects of OA and LOA on insulin signalling
To characterise any insulin potentiating effect that OA and
LOA may have on intracellular signalling we performed time and
dose studies for both NEFAs but in the presence of a sub-maximal
(20 nM) insulin concentration (Fig 1A). At this concentration,
insulin induced a modest increase in Akt phosphorylation, which
was barely detectable in untreated cells (Fig 1B,1C). However, Akt
phosphorylation was enhanced significantly when myotubes were
preincubated with OA or LOA for 16h in a dose-dependent
manner. This enhancement was significant at fatty acid concen-
trations as low as 200 mM (i.e. within the physiological range) and
was ,2-fold greater than that elicited by insulin treatment alone
when myotubes were pre-exposed to maximally effective doses
(700 mM) of OA or LOA (Fig 1B, 1C). The increase in Akt
phosphorylation was detectable after 9h but was not maximal until
16h of fatty acid treatment (Fig 1D,1E). Extended fatty acid
incubation periods up to 24h did not induce further increases in
Akt phosphorylation over and above that seen after 16h (data not
shown). Fig 1D and 1E show that the increase in signalling was not
restricted to Akt and that ERK1/2 phosphorylation was also
enhanced. In the absence of insulin, neither fatty acid had any
effect on Akt or ERK1/2 phosphorylation (Fig 1D, 1E). It is also
important to stress that treatment of myotubes with the vehicle (i.e.
BSA) alone did not enhance insulin-dependent phosphorylation of
Akt or ERK when compared with cells not exposed to the vehicle
(data not shown).
The increased sensitisation towards insulin elicited by both
NEFAs was most apparent and significant when monitored using a
sub-maximal insulin dose as no additional increase in Akt
phosphorylation was observed when OA- and LOA-treated
myotubes were treated with a maximally effective (100 nM)
insulin concentration (Fig 2A, 2B). Fig 2C shows that we observe
no major changes in the expression of the insulin receptor b-
subunit, IRS-1, PI3K-p85 subunit or of 39-phosphonositide lipid
phosphatase (PTEN), all of which lie upstream of Akt and ERK1/
2 in response OA or LOA treatment. Furthermore, neither OA
nor LOA had any effect on total Akt or ERK1/2 abundance thus
excluding this as a possible explanation for the net increase in their
phosphorylation. The data highlights that in addition to promot-
ing Ser473 phosphorylation, both OA and LOA induce an
equivalent gain in Akt-Thr308 phosphorylation (Fig 2C, 2D).
Equimolar phosphorylation of both sites is required for full
Fatty Acid Modulation of Insulin Sensitivity
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activation of Akt and consistent with this we observed elevated
phosphorylation of GSK3; a physiological downstream Akt target
(Fig 2C). Likewise, enhanced ERK1/2 activation promotes greater
phosphorylation/activation of CREB, a transcription factor
regulated downstream of the ERK pathway. The increase in
insulin-stimulated Akt phosphorylation induced by OA and LOA
was not restricted to L6 myotubes. Fig 2E shows that incubation of
human skeletal myotubes with OA or LOA caused a similar
enhancement in Akt and ERK1/2 phosphorylation in response to
insulin and that of GSK3 and CREB, which respectively lie
downstream of Akt and ERK signalling.
To understand how OA and LOA might enhance insulin-
signalling we monitored the effect of both fatty acids on p85-PI3-
kinase association with IRS1 and cellular PIP3 synthesis. As
anticipated, based on coprecipitation analysis, Fig 3A shows that
insulin induced p85-PI3K interaction with IRS1. This interaction
Figure 1. Effects of insulin, oleic acid (OA) and linoleic acid (LOA) on Akt and ERK phosphorylation in rat L6 myotubes. (A) L6
myotubes were serum-starved for 2h prior to stimulation with insulin (10 min) at concentrations indicated. (B,C) L6 myotubes were incubated with
serum-free media containing 2% (w/v) BSA (vehicle) 6 (B) oleic acid (OA) or (C) linoleic acid (LOA) at concentrations indicated, for 16h prior to
stimulation with insulin (20 nM, 10min). (D,E) L6 myotubes were incubated as in (B) 6 700 mM (D) OA or (E) LOA for times indicated, prior to
stimulation with insulin (20 nM, 10min). (A-E) Cell lysates were immunoblotted using antibodies against the proteins indicated. The asterisks signify a
significant change between the indicated bars (p,0.05).
doi:10.1371/journal.pone.0092255.g001
Fatty Acid Modulation of Insulin Sensitivity
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was not influenced by OA or LOA. Since Akt activation relies
upon insulin-dependent PIP3 synthesis it is possible that OA and
LOA may have enhanced production of this lipid. However, Fig
3B shows that, irrespective of whether muscle cells were incubated
in the absence or presence of OA or LOA, insulin stimulated PIP3
synthesis by ,2-fold.
OA and LOA help sustain Akt and ERK1/2 activation
Given that signalling events at the level of IRS1/PI3K were
unaffected by OA or LOA we investigated the possibility that
increased phosphorylation/activation of Akt and ERK1/2 by
insulin may be a consequence of their reduced dephosphorylation.
L6 myotubes were incubated in the absence or presence of these
fatty acids for 16h and subjected to an acute insulin challenge in
the penultimate 10 min period of this fatty acid incubation.
Myotubes were subsequently washed to remove extracellular
insulin and reincubated in media with 100 nM wortmannin (to
inhibit PI3K and any PIP3 synthesis still occurring following
removal of insulin) for up to 60 min post-wash. Muscle cells were
lysed at time points indicated in Fig 4A and Akt and ERK1/2
phosphorylation assessed in cell lysates. In the absence of OA or
LOA treatment, Akt and ERK1 were rapidly dephosphorylated
upon removal of insulin and returned to baseline by between 15-
30 min. However, both kinases retained a greater level of
phosphorylation (,2-fold at each post-wash time point) in
myotubes pretreated with OA or LOA (Fig 4B-E). Analysis of
the t1/2 with which Akt was dephosphorylated revealed that this
was increased from 13 min (untreated cells) to 18 min and 25 min
in cells that had been preincubated with OA or LOA, respectively.
Similarly, the t1/2 with which ERK1/2 become desphosphorylated
following cell incubation with OA and LOA was increased to 20
min and 25 min respectively, when compared with untreated cells
(12 min).
Both Akt and ERK1/2 are physiological targets for protein
phosphatase 2A (PP2A, [30,31]). We hypothesized that inhibiting
PP2A using okadaic acid should emulate the effect that we observe
following exposure to OA or LOA. Using a similar strategy to that
shown in Fig 4A, L6myotubes were pretreated with okadaic acid (or
vehicle (dH2O) alone) for 15 min and with insulin in the penultimate
10 min period prior to washing myotubes free from okadaic acid or
insulin and reincubation in media containing wortmannin for up to
60 min post-wash. Cells were lysed at time points specified in Fig 5A
for analysis of AktS473 and ERK1/2T202/Y204 phosphorylation and
reveals that pharmacological inhibition of PP2A induces heightened
Figure 2. Oleic acid (OA) and linoleic acid (LOA) enhance insulin sensitivity of rat L6 and primary human myotubes. (A) L6 myotubes
were incubated with serum-free media containing 2% (w/v) BSA (vehicle) 6 700 mM (A) oleic acid (OA) or (B) linoleic acid (LOA) for 16h prior to
stimulation with insulin at concentrations indicated (10min). (C, D) L6 myotubes were incubated as in (A) prior to stimulation with insulin (20 nM,
10min). (E) Human myotubes were incubated with 200 mM OA or LOA for 24h prior to stimulation with insulin (20 nM, 10min). Cell lysates from A-E
were subsequently immunoblotted using antibodies against the proteins indicated with quantification of phospho-Akt (Ser473 and Thr308) and
phospho-ERK1/2 shown in panel A,B and D expressed as mean 6 SEM of at least three experiments. The immunoblots shown in panel E are
representative of two separate experiments. The asterisks signify a significant change (p,0.05) between the indicated bars (A,B) or the insulin-
treatment alone (D).
doi:10.1371/journal.pone.0092255.g002
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and sustained phosphorylation of both kinases (Fig 5B and 5C) in a
manner comparable to that seen following fatty acid treatment (Fig
4B-E).
PP2Ac phosphorylation and demethylation
The above findings support the idea that OA and LOA may
enhance insulin signalling via repression of PP2A. To assess this
possibility we investigated the effect of OA, LOA and the SFA,
palmitate, on PP2A. Akt-directed insulin signalling is suppressed
by PA and this effect is partly reliant upon the known stimulatory
effect that PA exerts upon PP2A [32]. Fig 6A shows that, unlike
OA or LOA, sustained exposure of L6 myotubes to PA reduced
insulin-stimulated AktS473 phosphorylation (compare lane 2 with 4
and also lanes 6 and 8 with lane 4). This reduction appears to be
antagonised when PA-treated myotubes were co-incubated with
OA or LOA (compare Lane 4 with lanes 10 and 12). However, the
overall gain in phosphorylation remains significantly lower when
compared to myotubes exposed to OA or LOA alone (compare
lanes 6 and 8 with 10 and 12, respectively).
To assess whether PP2A may be regulated in a manner that
accounts for changes in Akt phosphorylation seen in response to
insulin, PA, OA and LOA (Fig 6A) we assessed tyrosine307
phosphorylation and carboxy-methylation of PP2Ac – two
different covalent modifications known to impact on PP2A
holenzyme assembly and PP2A activity [21]. Fig 6B shows that
compared to untreated cells, insulin was able to acutely induce
PP2AcY307 phosphorylation by 35%, but that this was negated in
myotubes preincubated with PA. In contrast, cellular pre-
treatment with OA or LOA not only induced a significant
enhancement in PP2AcY307 phosphorylation in response to
insulin, but blocked the reduction caused by PA. The ability of
OA and LOA to enhance PP2AcY307 phosphorylation in response
to insulin is not an acute event, but requires at least 9h of cell
treatment with either fatty acid to manifest (Fig 6C) and thus is
consistent with the time course over which there is a detectable
increase in insulin sensitivity as judged on the basis of Akt and
ERK phosphorylation (Fig 1D and 1E). It is also noteworthy, that
this fatty acid-induced increase in PP2AcY307 phosphorylation is
not restricted to cultured rat muscle cells as we also observe this
modulation in primary human muscle cells (data not shown). Src
has been implicated as the tyrosine kinase that phosphorylates
PPA2cY307 and consistent with this insulin, LOA and OA all
promoted Src activation based on phosphorylation of its Y416 site
(Fig 6B). It is noteworthy that SrcY416 phosphorylation can be
induced independently by insulin and both OA and LOA,
although the latter appear slightly more potent. There appears
to be no additional gain in phosphorylation of this site if myotubes
are co-treated with insulin and OA or LOA (Fig 6D). Analysis of
immunoprecipitated PP2Ac with an antibody detecting the
demethylated (inactive) protein revealed that insulin enhances
PP2Ac demethylation, but that this was abrogated in PA-treated
myotubes (Fig 6E). In contrast, both OA and LOA enhanced
accumulation/detection of demethylated PP2Ac that occurs with
insulin and, when coincubated with PA, repress the anti-
demethylation effect of the SFA.
Discussion
Numerous studies have demonstrated that increased availability
of SFAs negatively regulate skeletal muscle insulin sensitivity with
important knock-on consequences for processes such as gene
expression and cell metabolism that are normally regulated by the
hormone [8,33–35]. In contrast, considerable evidence supports
the view that insulin sensitivity is positively correlated with supply
of MUFAs and PUFAs and that, in many instances, their provision
not only promotes beneficial metabolic changes but negate some
of the adverse effects associated with SFA oversupply [18,35,36].
Figure 3. Effects of insulin, oleic acid (OA) and linoleic acid (LOA) on p85/IRS1 association and cellular PIP3 generation in L6
myotubes. (A,B) L6 myotubes were incubated with serum-free media containing 2% (w/v) BSA (vehicle) 6 700 mM (A) oleic acid (OA) or (B) linoleic
acid (LOA) for 16h prior to stimulation with insulin at concentrations indicated (10min). (A) IRS-1 was immunoprecipitated from whole cell lysates
(WCL) using an anti-IRS-1 antibody. The immunopellet was probed with an anti-p85 antibody. (B) Cells were treated as in (A) lysed and assayed for
PIP3 content [28]. The bar graph values (A & B) are presented as mean 6 SEM of three separate experiments.
doi:10.1371/journal.pone.0092255.g003
Fatty Acid Modulation of Insulin Sensitivity
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Indeed, previous work from our group has demonstrated that,
unlike PA, provision of MUFAs (e.g. palmitoleate and oleate) can
induce insulin-like effects upon distal cellular responses, such as
glucose uptake by inducing plasma membrane recruitment of
glucose transporters [36]. Intriguingly, this effect does not involve
activation of molecules involved in proximal insulin signalling (e.g.
PI3K, Akt) and, moreover, no additional enhancement in glucose
uptake is observed when muscle cells are simultaneously
challenged with the MUFA and a maximally effective concentra-
tion of insulin [36]. This latter finding implies that signals initiated
Figure 4. Oleic acid (OA) and linoleic acid (LOA) enhance and prolong insulin-dependent phosphorylation of Akt and ERK in L6
myotubes. The experimental approach used to test the effect of OA and LOA provision on Akt and ERK1/2 phosphorylation is depicted in (A). L6
myotubes were incubated with serum-free media containing 2% (w/v) BSA (vehicle) 6 700 mM (B and C) oleic acid (OA) or (D and E) linoleic acid
(LOA) for 16h prior to stimulation with insulin (20 nM, 10min). Cells were washed to remove insulin and subsequently incubated with 100 nM
wortmannin (WM) and lysed at times indicated. Immunoblots and relevant quantification of phospho-Akt and phospho-ERK1/2 in L6 myotubes
incubated with OA (B,C) or LOA (D,E). Data in the bar graphs is presented as mean 6 SEM (n= 3) with asterisks indicating a significant change
(p,0.05) between the respective filled (fatty acid treatment) and unfilled (control) bar at each time point.
doi:10.1371/journal.pone.0092255.g004
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by palmitoleate and insulin ultimately converge upon a common
end-point that promotes translocation and/or activation of glucose
transporters. The current study indicates that, in addition to such
effects, incubating myotubes with insulin at a sub-maximal
concentration unveils an insulin-sensitising effect of unsaturated
fatty acids, such as OA and LOA, which is likely to involve
suppression of PP2A action.
Several groups have reported hyperactivation of PP2A in
response to sustained oversupply of glucose and SFAs (i.e.
glucolipotoxicity), which may be important in the pathogenesis
of insulin resistance [22,37–39]. The heightened PP2A activity
that is observed under such circumstances may not only involve an
increase in PP2Ac expression but also that of the many regulatory
PP2A subunits [40], a proposition based on the finding that Ptpa,
B55b and B56a are all elevated in muscle and liver of insulin
resistant (ZDF) rats [22]. Whilst we cannot discount the possibility
that OA and LOA may repress expression of the catalytic and
certain regulatory PP2A subunits, our finding that they restrain
PA-induced changes in PP2Ac phosphorylation/methylation is
likely to be of significance in helping to counter PP2A
hyperactivation by SFAs. The differential effect that unsaturated
and saturated fatty acids have upon PP2A may be explained, in
part, by their contrasting effects on Src, which affects PP2A
activity via direct phosphorylation of PP2Ac at Tyr307 [39,41]. In
line with previous studies [42], we show that PA inhibits Src
activation based on a reduction in SrcY416 phosphorylation and a
concomitant reduction in the downstream phosphorylation of
PP2Ac on Tyr307 (Fig 6B). As a consequence, PP2Ac would be
expected to be more active under these circumstances leading to
counter-modulation of signalling molecules activated by insulin. In
sharp contrast, as reported in other cell types [43,44], both OA
and LOA induce ScrY416 phosphorylation to a level comparable if
not greater than that seen in response to insulin - thus promoting a
concomitant increase in PP2Ac tyrosine phosphorylation (Fig 6C,
6D). Unlike PA, the modulation of Src by OA and LOA in our
model would suppress PP2A action leading, as we show, to greater
and more sustained activation of some of its targets (i.e. Akt and
ERK1/2) by insulin. The molecular basis for this differential fatty
acid effect on Src is currently unclear but may depend upon their
ability to activate membrane bound fatty acid receptors (e.g.
GPR40 and GPR120) that couple to signalling molecules
influencing the activation status of Src. Activation of such
Figure 5. Okadaic acid emulates the insulin-sensitising effect of oleic acid (OA) and linoleic acid (LOA) upon Akt and ERK
phosphorylation in L6 myotubes. L6 myotubes were incubated with serum-free media containing okadaic acid (100 nM) or vehicle (dH2O) for 15
min and with insulin (20 nM) during the penultimate 10 min period of this incubation. Cells were washed and then maintained in serum-free media
containing wortmannin (WM, 100 nM) and lysed at times indicated. Cell lysates were subsequently immunoblotted using antibodies against the
proteins indicated. Data in the bar graphs is presented as mean 6 SEM (n= 3) with asterisks indicating a significant change (p,0.05) between the
respective filled (okadaic acid treatment) and unfilled (control) bar at each time point.
doi:10.1371/journal.pone.0092255.g005
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receptors has been implicated in OA-induced activation of
ERK1/2 and AP-1 DNA binding activity through a mechanism
involving Src in MCF-7 breast cancer cells [43]. Whether such a
mechanism explains activation of Src by OA and LOA in skeletal
muscle cells and the rather gradual tyrosine phosphorylation and
demethylation of PP2Ac is currently unknown, although, we do
have evidence for GPR40 expression in L6 myotubes (data not
shown). Defining whether GPR40 is a component of the
mechanism by which OA and LOA enhance skeletal muscle
insulin-sensitivity represents an important investigative goal of
future work.
Our results indicate that both OA and LOA promote an
increase in proximal insulin signalling and can attenuate the effect
that PA has upon Src and PP2Ac phosphorylation. However, it is
apparent, from comparing the net changes, that the ability with
which both OA and LOA enhance insulin-dependent Akt
phosphorylation is somewhat compromised when cells are also
incubated with PA (Fig 6A). We recently demonstrated that PA
uptake into myotubes is not affected by co-provision of MUFAs
and that under these circumstances there is no reduction in PA-
derived ceramide synthesis [18]. Consequently, sustained cer-
amide generation will activate atypical PKCs that physically
associate with and negatively regulate Akt activation [7,8].
Figure 6. Effects of insulin, palmitate (PA), oleic acid (OA) and linoleic acid (LOA) on Akt, Src and PP2Ac phosphorylation and PP2Ac
demethylation in L6 myotubes. L6 myotubes were incubated with serum-free media containing 2% (w/v) BSA (vehicle)6 700 mM palmitate (PA),
oleic acid (OA) or linoleic (LOA) for 16h or for times indicated. In some experiments, cells were treated with fatty acids either alone or in combination
as indicated or stimulated with insulin (20 nM, 10min) as indicated (A-E). Cell lysates were immunoblotted using antibodies against the proteins/
phospho-proteins indicated. In (E) PP2Ac was immunoprecipitated from cell lysates and the immunopellet probed with an antibody recognising
demethylated PP2Ac. Bar graphs values (A, n = 3; B, n = 4 and E, n = 7) are Mean 6 SEM. The asterisks in (A) signify a significant change (p,0.05)
compared to the insulin treated value (Lane 2) or between the indicated bars (B & E).
doi:10.1371/journal.pone.0092255.g006
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However, despite the inability to repress ceramide synthesis from
the SFA it is apparent that MUFA and PUFA provision mitigate
some of the deleterious effects that PA has upon insulin-action via,
for example, its ability to activate PP2A.
In summary, the enhanced insulin sensitivity associated with
OA and LOA provision is likely to reflect the ability of these
unsaturated fatty acids to modulate methylation and phosphory-
lation of PP2Ac in a manner that represses phosphatase action.
Our observations support the view that diets enriched with OA
and/or LOA may confer important insulin-sensitising and
metabolic benefits. Indeed, recent work assessing dietary fatty
acid composition and insulin sensitivity in young adults found that
replacing dietary PA with OA benefits clinically relevant measures
of metabolic wellbeing, including insulin sensitivity [45]. Although
the molecular events underpinning this finding remained unclear,
the authors noted that, unlike individuals on an OA-enriched diet,
those consuming a PA-enriched diet had more of their fatty acid
routed towards acylcarnitine and ceramide production consistent
with the idea that PA promotes greater metabolic dysfunction,
whereas OA would be not be disruptive in this regard.
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